Cardiovascular Research
| Name | Preis | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acidic phospholipase A2 CoaPLA2 | Anmelden | Acidic phospholipase A2 CoaPLA2 | ||||||||||||||||
|
||||||||||||||||||
| FAS Protein- Human Factor Related Apoptosis Recombinant protein | Anmelden | FAS Protein- Human Factor Related Apoptosis Recombinant protein | ||||||||||||||||
|
||||||||||||||||||
| Human HSP110de9 Recombinant Protein | Anmelden | Human HSP110de9 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| Ostreid herpesvirus Putative apoptosis inhibitor ORF87 Recombinant Protein | Anmelden | Ostreid herpesvirus Putative apoptosis inhibitor ORF87 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| Synthetic SNAP Protein | Anmelden | Synthetic SNAP Protein | ||||||||||||||||
|
||||||||||||||||||
| Peroxisome proliferator-activated receptor alpha(PPARA) | Anmelden | Peroxisome proliferator-activated receptor alpha(PPARA) | ||||||||||||||||
|
||||||||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit alpha(PIK3R1) | Anmelden | Phosphatidylinositol 3-kinase regulatory subunit alpha(PIK3R1) | ||||||||||||||||
|
||||||||||||||||||
| BCL2 protein - Apoptosis regulator Bcl-2(BCL2) | Anmelden | BCL2 protein - Apoptosis regulator Bcl-2(BCL2) | ||||||||||||||||
|
||||||||||||||||||
| Ulocuplumab Biosimilar - Anti-CXCR4, CD184 mAb - Research Grade | Anmelden | Ulocuplumab Biosimilar - Anti-CXCR4, CD184 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Ulocuplumab Biosimilar - Anti-CXCR4, CD184 mAb - Research Grade | Anmelden | Ulocuplumab Biosimilar - Anti-CXCR4, CD184 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Acidic phospholipase A2 CoaPLA2 | Anmelden | Acidic phospholipase A2 CoaPLA2 | ||||||||||||||||
|
||||||||||||||||||
| FAS Protein/ Human Factor Related Apoptosis Recombinant protein | Anmelden | FAS Protein/ Human Factor Related Apoptosis Recombinant protein | ||||||||||||||||
|
||||||||||||||||||
| Human HSP110de9 Recombinant Protein | Anmelden | Human HSP110de9 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| Ostreid herpesvirus Putative apoptosis inhibitor ORF87 Recombinant Protein | Anmelden | Ostreid herpesvirus Putative apoptosis inhibitor ORF87 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| Synthetic SNAP Protein | Anmelden | Synthetic SNAP Protein | ||||||||||||||||
|
||||||||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit alpha(PIK3R1) | Anmelden | Phosphatidylinositol 3-kinase regulatory subunit alpha(PIK3R1) | ||||||||||||||||
|
||||||||||||||||||
| BCL2 protein / Apoptosis regulator Bcl-2(BCL2) | Anmelden | BCL2 protein / Apoptosis regulator Bcl-2(BCL2) | ||||||||||||||||
|
||||||||||||||||||
| Peroxisome proliferator-activated receptor alpha(PPARA) | Anmelden | Peroxisome proliferator-activated receptor alpha(PPARA) | ||||||||||||||||
|
||||||||||||||||||
| Ongericimab Biosimilar - Anti-PCSK9 mAb - Research Grade | Anmelden | Ongericimab Biosimilar - Anti-PCSK9 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Ongericimab Biosimilar - Anti-PCSK9 mAb - Research Grade | Anmelden | Ongericimab Biosimilar - Anti-PCSK9 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Recaticimab Biosimilar - Anti-PCSK9 mAb - Research Grade | Anmelden | Recaticimab Biosimilar - Anti-PCSK9 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Recaticimab Biosimilar - Anti-PCSK9 mAb - Research Grade | Anmelden | Recaticimab Biosimilar - Anti-PCSK9 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| AMPK alpha1 Mouse Monoclonal Antibody(5G11) | Anmelden | AMPK alpha1 Mouse Monoclonal Antibody(5G11) | ||||||||||||||||
|
||||||||||||||||||
| Ebronucimab Biosimilar - Anti-PCSK9 mAb - Research Grade | Anmelden | Ebronucimab Biosimilar - Anti-PCSK9 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Ebronucimab Biosimilar - Anti-PCSK9 mAb - Research Grade | Anmelden | Ebronucimab Biosimilar - Anti-PCSK9 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||


